Your browser doesn't support javascript.
loading
Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice.
Li, Dan; Li, Nan; Zhang, Yi-Fan; Fu, Haiying; Feng, Mingqian; Schneider, Dina; Su, Ling; Wu, Xiaolin; Zhou, Jing; Mackay, Sean; Kramer, Josh; Duan, Zhijian; Yang, Hongjia; Kolluri, Aarti; Hummer, Alissa M; Torres, Madeline B; Zhu, Hu; Hall, Matthew D; Luo, Xiaoling; Chen, Jinqiu; Wang, Qun; Abate-Daga, Daniel; Dropulic, Boro; Hewitt, Stephen M; Orentas, Rimas J; Greten, Tim F; Ho, Mitchell.
Afiliação
  • Li D; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; School of Life Sciences, East China Normal University, Shanghai, China.
  • Li N; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Zhang YF; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Fu H; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Department of Immunology, Norman Bethune College of Medicine, Jilin University, Changchun, China.
  • Feng M; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Schneider D; Lentingen, a Miltenyi Biotec Company, Gaithersburg, Maryland.
  • Su L; Cancer Research Technology Program, Leidos Biomedical Research, Inc, Frederick, Maryland.
  • Wu X; Cancer Research Technology Program, Leidos Biomedical Research, Inc, Frederick, Maryland.
  • Zhou J; IsoPlexis Corporation, Branford, Connecticut.
  • Mackay S; IsoPlexis Corporation, Branford, Connecticut.
  • Kramer J; Animal Facility, Leidos Biomedical Research, Inc, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Duan Z; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Yang H; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Kolluri A; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Hummer AM; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Torres MB; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Zhu H; Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.
  • Hall MD; Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.
  • Luo X; Collaborative Protein Technology Resource, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Chen J; Collaborative Protein Technology Resource, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Wang Q; School of Life Sciences, East China Normal University, Shanghai, China.
  • Abate-Daga D; Departments of Immunology, Cutaneous Oncology, and Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Dropulic B; Lentingen, a Miltenyi Biotec Company, Gaithersburg, Maryland.
  • Hewitt SM; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Orentas RJ; Seattle Children's Research Institute, Seattle, Washington.
  • Greten TF; Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Ho M; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: homi@mail.nih.gov.
Gastroenterology ; 158(8): 2250-2265.e20, 2020 06.
Article em En | MEDLINE | ID: mdl-32060001
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunoterapia Adotiva / Carcinoma Hepatocelular / Glipicanas / Receptores de Antígenos Quiméricos / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Aged80 Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunoterapia Adotiva / Carcinoma Hepatocelular / Glipicanas / Receptores de Antígenos Quiméricos / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Aged80 Idioma: En Ano de publicação: 2020 Tipo de documento: Article